Suchergebnisse - "Jin, Qingchun"

PubPharm (14)

1

Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer

enthalten in: NPJ breast cancer | 2024

von Morganti, S. | Jin, Q. | Vincuilla, J. | +15

2

Exemestane plus everolimus and palbociclib in metastatic breast cancer : clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial

enthalten in: Nature communications | 2024

von Gómez Tejeda Zañudo, J. | Barroso-Sousa, R. | Jain, E. | +15

3

Axillary Nodal Response to Neoadjuvant T-DM1 Combined with Pertuzumab in a Prospective Phase II Multi-Institution Clinical Trial

enthalten in: Journal of the American College of Surgeons | 2024

von Weiss, A. | Jin, Q. | Waks, A. | +8

4

Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Morganti, S. | Gibson, C. | Jin, Q. | +20

5

Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer

enthalten in: Cancer research | 2023

von Hermida-Prado, F. | Xie, Y. | Sherman, S. | +38

6

Identifying Patterns and Barriers in OncotypeDX Recurrence Score Testing in Older Patients With Early-Stage, Estrogen Receptor-Positive Breast Cancer : Implications for Guidance and Reimbursement

enthalten in: JCO oncology practice | 2023

von Trapani, D. | Jin, Q. | Block, C. | +11

7

Circulating progenitor cells and outcomes in patients with coronary artery disease

enthalten in: International journal of cardiology | 2023

von Dhindsa, D. | Desai, S. | Jin, Q. | +17

8

HER2-low inflammatory breast cancer : Clinicopathologic features and prognostic implications

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Tarantino, P. | Niman, S. | Erick, T. | +14

9

Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer

enthalten in: JAMA oncology | 2022

von Tarantino, P. | Jin, Q. | Tayob, N. | +13

CommentIn: JAMA Oncol. 2023 Jan 1;9(1):146-147. - PMID 36326737

10

Genomic and Transcriptomic Determinants of Resistance to CDK4/6 Inhibitors and Response to Combined Exemestane plus Everolimus and Palbociclib in Patients with Metastatic Hormone Receptor Positive Breast Cancer

enthalten in: bioRxiv.org | 2022

von Gómez Tejeda Zañudo, J. | Barroso-Sousa, R. | Jain, E. | +15